Primary Cutaneous CD30-Positive Lymphoproliferative Disorder With Gamma-Delta T-Cells: A Molecular-Annotated Case

David Weiner1, Joi B Carter2, Frederick Lansigan3

  • 1Department of Dermatology, Johns Hopkins Hospital, Baltimore, Maryland, USA.

PubMed

Insights

This study details a rare case of CD30-positive lymphoproliferative disorder (CD30+LPD) in gamma-delta T-cells, presenting as indolent primary cutaneous anaplastic large cell lymphoma (pcALCL) and lymphomatoid papulosis (LyP). Molecular analysis revealed specific mutations and aneuploidy, aiding in understanding this rare T-cell lymphoma.

Area of Science:

  • Hematology
  • Oncology
  • Dermatology

Background:

  • CD30-positive lymphoproliferative disorders (CD30+LPD) are a group of skin conditions.
  • Gamma-delta T-cell lymphomas are rare subtypes of cutaneous lymphomas.

Purpose of the Study:

  • To present a rare case of CD30+LPD composed of gamma-delta T-cells.
  • To analyze the clinical, histopathologic, and molecular features of this indolent T-cell lymphoma.
  • To review the literature on similar rare cases.

Main Methods:

  • Clinical follow-up and multiple biopsies over 4 years.
  • Histopathologic examination to determine lymphoma type.
  • Whole-exome sequencing to identify mutations.
  • Copy-number profiling to detect aneuploidy.

Main Results:

  • The patient was diagnosed with primary cutaneous anaplastic large cell lymphoma (pcALCL) and lymphomatoid papulosis (LyP).
  • Sequencing identified missense mutations in ADGRA2, EPHA7, ERBB2, LRP1B, NOD1, RAF1, RICTOR, and WDR90.
  • Aneuploidy, including gain of 1q and loss of 16q and 19p13.3, was observed.
  • No gene fusions were detected.

Conclusions:

  • The findings suggest a complex genetic landscape in indolent CD30+LPD with gamma-delta T-cells.
  • While specific mutations and aneuploidy were identified, they were insufficient for a definitive pcGDTCL diagnosis.
  • This case contributes to understanding rare T-cell lymphomas and their molecular underpinnings.